Abstract:
The present invention relates to a smart moxibustion apparatus comprising: an accommodation unit which accommodates materials for moxibustion; a support unit which supports the accommodation unit by being arranged to be separated at a constant distance from the external surface of the accommodation unit so that the accommodation unit is arranged in a body; a sensor unit which is arranged in the lower part of the accommodation unit in order to measure the temperature of the inner space of the accommodation unit; and a monitoring unit which is fixed to the external surface of the support unit by being connected to the sensor unit and includes a display part for indicating temperature sensed by the sensor unit. Accordingly, the smart moxibustion apparatus measures the accurate temperature of a space between a part in which the materials for moxibustion are burn and a body part of a patient through the sensor unit and displays measured temperature so that an operator recognizes the measured temperature, thereby preventing accidents such as burn on the patient and operator and being able to perform effective and stable moxibustion medical treatment.
Abstract:
본 발명은 행인으로부터 강력한 티로시나제 억제활성을 나타내는 정유성분을 대량으로 추출하는 추출방법 및 이 추출물을 유효성분으로 함유하는 미백용 화장료 조성물에 관한 것으로, 상세하게는 행인으로부터 기존 정유 추출방법보다 보다 강력한 티로시나제 억제활성을 나타내는 정유성분을 대량으로 추출하는 추출방법을 발견하고 이 제법으로 얻어진 정유성분들이 우월한 효과를 나타내므로 기존 정유성분 추출방법보다 탁월한 품질의 화장품을 제조할 수 있다.
Abstract:
The present invention relates to a pharmaceutical composition for preventing or treating cancer which includes Aruncus dioicus var. kamtschaticus extract, aruncin B represented by chemical formula 1, or pharmaceutically acceptable salt thereof as an active ingredient, to an apoptosis inducing agent of cancer cells, and to health supplements for preventing or improving cancer. The Aruncus dioicus var. kamtschaticus extract, aruncin B represented by chemical formula 1, or pharmaceutically acceptable salt thereof has effects of preventing, improving or treating various kinds of cancers such as acute leukemia, breast cancer, and colorectal cancer. Such substances work by a mechanism which induces apoptosis of cancer cells so that the substances can be usefully applied as the apoptosis inducing agent.
Abstract:
The present invention relates to a composition, a pharmaceutical composition, and health functional food containing extracts from plantago seed and Poria cocos as active ingredients for treating and preventing obesity. The extracts from plantago seed and Poria cocos by the present invention have an excellent anti-obesity effect: reducing not only body weight, body fat, and blood lipid concentration but also the diameter of lipid in liver, epididymis, and pancreatic cells and controlling appetite and dietary intake suppression by hypothalamus. The mixed herbal extract from plantago seed and Poria cocos can be useful as a pharmaceutical composition for preventing and treating obesity.
Abstract:
The present invention provides a use of a Taraxacum officinale extract as a medicine and/or a food for treating, alleviating, and/or preventing either amnesia or neurodegenerative diseases. By the present invention, either amnesia or neurodegenerative diseases can be effectively treated, alleviated, and/or prevented.
Abstract:
PURPOSE: An Aruncus dioicus var. kamtschaticus extract, aruncin B, or a pharmaceutically acceptable salt thereof is provided to prevent, alleviate, or treat various cancers including acute leukemia, breast cancer, and colon cancer, and be used as an apoptosis inducer by a cancer cell apoptotic mechanism. CONSTITUTION: A pharmaceutical composition for preventing or treating cancer contains an Aruncus dioicus var. kamtschaticus extract as an active ingredient. The extract is prepared from the aerial part of Aruncus dioicus var. kamtschaticus using methylene chloride. An apoptosis inducer contains the extract as an active ingredient. A health functional food for preventing or treating cancer contains the extract as an active ingredient. The pharmaceutical composition also contains a compound of chemical formula 1 or a pharmaceutically acceptable salt thereof as an active ingredient. The compound is isolated and purified from Aruncus dioicus var. kamtschaticus.
Abstract:
본 발명은 삼백초 추출물의 유효성분인 사우치논을 함유하는 조성물에 관한 것으로, 본 발명의 사우치논은 약물중독의 지표로 사용되는 조건화 장소선호도 (conditional place preference)를 이용하여 중독성 약물에 대한 선호도를 감소시켜 약물 중독 및 금단 증상의 예방 및 치료를 위한 약학조성물 및 건강보조식품에 유용하게 이용될 수 있다.